BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 88 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $53,000 | -32.1% | 998 | -22.0% | 0.00% | – |
Q2 2020 | $78,000 | +9.9% | 1,279 | -1.5% | 0.00% | – |
Q1 2020 | $71,000 | -22.0% | 1,298 | -18.4% | 0.00% | – |
Q4 2019 | $91,000 | +26.4% | 1,591 | +17.9% | 0.00% | – |
Q3 2019 | $72,000 | -11.1% | 1,349 | 0.0% | 0.00% | – |
Q2 2019 | $81,000 | +8.0% | 1,349 | +11.4% | 0.00% | – |
Q1 2019 | $75,000 | +1.4% | 1,211 | 0.0% | 0.00% | – |
Q4 2018 | $74,000 | +57.4% | 1,211 | +50.1% | 0.00% | – |
Q3 2018 | $47,000 | +11.9% | 807 | -14.6% | 0.00% | – |
Q2 2018 | $42,000 | +2.4% | 945 | +2.1% | 0.00% | – |
Q1 2018 | $41,000 | -31.7% | 926 | -33.4% | 0.00% | – |
Q4 2017 | $60,000 | -20.0% | 1,390 | -13.0% | 0.00% | – |
Q3 2017 | $75,000 | -2.6% | 1,597 | +2.5% | 0.00% | – |
Q2 2017 | $77,000 | -8.3% | 1,558 | 0.0% | 0.00% | – |
Q1 2017 | $84,000 | -2.3% | 1,558 | 0.0% | 0.00% | – |
Q4 2016 | $86,000 | +132.4% | 1,558 | +90.9% | 0.00% | – |
Q3 2016 | $37,000 | -57.0% | 816 | -62.7% | 0.00% | – |
Q2 2016 | $86,000 | – | 2,187 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |